coronavirus
cov
positivesens
singlestrand
rna
virus
caus
number
respiratori
diseas
mammal
last
two
decad
two
beta
coronavirus
respons
epidem
outbreak
atyp
pneumonia
case
first
outbreak
caus
sever
acut
respiratori
syndrom
coronaviru
sarscov
later
epidem
relat
middl
east
respiratori
syndrom
coronaviru
merscov
global
mortal
rate
sarscov
document
merscov
death
outcom
progress
acut
respiratori
distress
syndrom
multipl
organ
failur
respiratori
diseas
caus
cov
believ
result
zoonot
transmiss
specif
anim
genom
sequenc
studi
suggest
potenti
zoonot
reservoir
sarscov
bat
camel
thought
probabl
vector
reservoir
merscov
decemb
multipl
case
unknown
viral
pneumonia
report
wuhan
china
time
patient
live
work
near
local
seafood
market
genom
sequenc
patient
specimen
collect
lower
respiratori
tract
reveal
implic
unpreced
type
coronaviru
later
name
novel
coronaviru
analysi
next
gener
sequenc
data
show
similar
sarscov
merscov
genom
ident
respect
accord
situat
report
februari
current
epidem
outbreak
pneumonia
caus
global
distribut
affect
countri
confirm
case
coronaviru
diseas
live
china
report
number
death
pneumonia
case
clinic
featur
similar
report
sarscov
merscov
patient
present
fever
dri
cough
dyspnea
bilater
groundglass
opac
consolid
chest
seen
ct
imag
unlik
sarscov
merscov
patient
rare
show
sign
enter
diseas
like
diarrhea
also
patient
present
upper
respiratori
tract
symptom
like
sore
throat
rhinorrhea
transmiss
mode
may
similar
sarscov
merscov
airborn
droplet
contact
infect
person
mean
incub
period
estim
day
confid
interv
rang
day
like
sarscov
may
use
angiotensinconvert
enzym
potenti
receptor
host
cell
infect
current
antivir
therapi
vaccin
avail
coronaviru
infect
attempt
trend
acceler
combat
current
epidem
outbreak
februari
worldwid
protein
data
bank
establish
coronaviru
resourc
facilit
target
base
drug
design
effort
current
global
threat
list
coronaviru
resourc
crystal
team
shanghai
technic
univers
abl
resolv
structur
main
proteas
threedimension
represent
monom
main
proteas
deciph
crystal
seen
figur
main
proteas
mpro
also
less
commonli
known
proteas
believ
essenti
coronavirus
replic
cycl
posttransl
process
rna
replicas
machineri
mpro
usual
present
homodim
mani
coronavirus
share
signific
homolog
regard
threedimension
structur
amino
acid
sequenc
proteolyt
enzym
therefor
mpro
repres
conserv
molecular
target
design
broad
spectrum
anticov
drug
interest
studi
bind
featur
fda
approv
drug
recent
known
main
proteas
structur
high
sequenc
homolog
sarscov
crystal
main
proteas
superimpos
align
refer
crystal
sarscov
main
proteas
code
matchmak
match
align
tool
embed
ucsf
chimera
util
superimpos
align
chain
two
crystal
matchmak
tool
superimpos
two
protein
use
residu
type
secondari
structur
inform
hand
match
align
tool
align
superimpos
protein
depend
residu
spatial
proxim
although
bind
site
well
character
inhibitor
within
mani
mpro
crystal
appli
dogsitescor
onlin
tool
predict
describ
potenti
bind
pocket
within
recent
releas
crystal
dogsitescor
tool
detect
potenti
bind
pocket
within
specif
protein
rank
pocket
accord
size
surfac
area
druggabl
score
use
fda
approv
drug
librari
resourc
potenti
hit
virtual
screen
fda
approv
drug
librari
download
zinc
databas
februari
time
download
librari
contain
fda
approv
drug
drug
upload
conform
mcule
onlin
drug
discoveri
platform
employ
mcule
platform
screen
fda
approv
drug
main
proteas
crystal
autodock
vina
tool
embed
mcule
platform
appli
carri
acceler
screen
mpro
crystal
code
download
coronaviru
resourc
worldwid
protein
data
bank
screen
remov
water
molecul
bound
ligand
inhibitor
crystal
use
ucsf
chimera
version
local
machin
mcule
platform
automat
ad
gasteig
charg
polar
hydrogen
atom
upload
crystal
mpro
use
onlin
autodock
tool
screen
protocol
use
bind
site
area
angstrom
coordin
x
z
otherwis
use
default
paramet
option
screen
fda
approv
drug
process
crystal
screen
output
list
rank
drug
accord
minimum
bind
energi
mpro
crystal
pick
top
ten
hit
output
structurebas
virtual
screen
process
screen
top
hit
mpro
crystal
repeat
confirm
mcule
platform
result
use
ucsf
chimera
version
local
machin
run
screen
process
ucsf
chimera
softwar
provid
easili
access
interfac
process
ligand
target
softwar
easili
add
polar
hydrogen
atom
gasteig
charg
also
ignor
nonstandard
amino
acid
residu
ucsf
chimera
also
provid
flexibl
way
custom
autodock
vina
tool
use
local
vina
tool
version
molecular
dock
paramet
use
similar
use
except
exhaust
search
increas
eight
clean
conform
top
ten
drug
prepar
use
marvinsketch
version
hit
ligandtarget
complex
least
bind
energi
pose
save
pdb
file
evalu
discoveri
studio
visual
version
dynam
simul
yasara
dynam
version
molecular
dynam
md
simul
effici
method
predict
ligandtarget
interact
consid
target
flexibl
atom
molecul
whole
complex
allow
move
interact
specif
period
timeth
trajectori
atom
molecul
determin
newton
equat
motion
potenti
energi
interact
atom
determin
molecular
mechan
differ
forc
field
molecular
dynam
simul
ligandtarget
complex
least
bind
energi
pose
done
yasara
dynam
protocol
md
simul
includ
optim
hydrogen
bond
network
enhanc
stabil
solut
pka
anticip
finetun
proton
state
amino
acid
residu
ph
valu
sodium
chlorid
ion
ad
concentr
excess
either
na
cl
neutral
complexfollow
steepest
descent
simul
anneal
minim
remov
possibl
clash
simul
allow
run
nanosecond
use
forc
field
solut
ligand
waterth
cutoff
valu
angstrom
van
der
waal
forc
default
paramet
use
amber
cutoff
limit
use
electrostat
forc
employ
particl
mesh
ewald
algorithm
equat
motion
appli
multipl
timestep
femtosecond
bond
interact
femtosecond
nonbond
interact
temperatur
pressur
atm
evalu
solut
rootmeansquar
deviat
rmsd
function
simul
time
first
nanosecond
consid
equilibr
time
exclud
analysi
use
crystal
sarscov
mpro
refer
abl
success
align
superimpos
crystal
main
proteas
accord
figur
crystal
well
superimpos
signific
overlap
deviat
notic
cterminu
region
two
crystal
simplic
illustr
chain
consid
align
superimposit
two
superimpos
crystal
align
accord
residu
spatial
proxim
figur
report
sequenc
align
output
mpro
sarscov
mpro
two
crystal
well
align
ident
percentag
result
fall
favor
previou
studi
indic
main
proteas
enzym
highli
conserv
mani
coronaviru
member
therefor
proteolyt
enzym
may
use
structurebas
screen
studi
design
broad
spectrum
anticov
drug
employ
dogsitescor
gridbas
tool
abl
detect
sever
potenti
bind
pocket
within
chain
main
proteas
crystal
report
first
three
pocket
tabl
bind
pocket
rank
accord
size
surfac
area
druggabl
score
first
pocket
prefer
bind
site
inhibitor
report
mani
crystal
studi
cov
mpro
locat
pocket
one
use
coordin
grid
box
setup
dock
analysi
predict
bind
pocket
within
crystal
also
well
illustr
figur
chemic
clinic
characterist
top
ten
hit
least
bind
energi
dock
score
list
tabl
fda
approv
drug
rank
accord
minimum
bind
energi
main
proteas
accord
tabl
four
drug
anticanc
agent
due
safeti
concern
neglect
analysi
studi
also
ignor
perampanel
loxapin
consider
due
signific
central
nervou
system
effect
chosen
conivaptan
azelastin
molecular
dock
dynam
analysi
due
rel
safeti
therebi
may
repurpos
molecular
dynam
md
analysi
comput
demand
process
therefor
focus
conivaptan
azelastin
save
limit
comput
power
chemic
structur
ten
drug
shown
figur
molecular
dock
imag
show
predomin
involv
differ
hydrophob
interact
ligand
conivaptan
azelastin
amino
acid
residu
main
proteas
except
format
hydrogen
bond
glutamin
residu
mpro
conivaptan
twodimension
imag
dock
analysi
conivaptan
azelastin
mpro
crystal
shown
figur
evid
conivaptan
interact
mpro
activ
site
azelastin
ligandprotein
complex
least
bind
energi
pose
save
pdb
file
md
simul
accord
potenti
energi
plot
figur
conivaptanmpro
complex
azelastinempro
complex
stabl
equilibrium
phase
base
md
analysi
report
conivaptan
interact
mpro
activ
site
residu
azelastin
simul
period
interact
bond
hydrophob
result
seen
figur
fall
agreement
find
dock
studi
ligand
proxim
activ
site
residu
target
may
indic
stronger
bind
regard
conivaptan
azelastin
abl
maintain
low
ligand
movement
rootmeansquar
deviat
rmsd
nt
exceed
angstrom
seen
figur
superpos
receptor
refer
structur
gener
plot
final
analysi
molecular
dynam
shown
conivaptan
may
undergo
conform
chang
compar
azelastin
simul
time
figur
show
ligand
conform
rootmeansquar
deviat
rmsd
superpos
ligand
refer
structur
report
optim
bind
featur
conivaptan
azelastin
main
proteas
protein
target
use
molecular
dock
simul
studi
consider
